Retraction: Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma

Documenti analoghi

• Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma
  di: Liu, Ping, et al.
  Pubblicazione: (2015)
• Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma
  di: Chen, Bin, et al.
  Pubblicazione: (2015)
• Retraction Note: Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma
  di: Qin, Yan-Guo, et al.
  Pubblicazione: (2020)
• Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
  di: Ni, Miaozhong, et al.
  Pubblicazione: (2015)
• Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery
  di: Vasconcelos, Aimee, et al.
  Pubblicazione: (2015)